Walleye Trading’s Strongbridge Biopharma plc. SBBP Stock Holding History

Walleye Trading’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26,619	Closed	-$101K	–	4840
2020 Q2	$101K	Buy	+26,619	New	+$79.8K	﹤0.01%	3504

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Trading's SBBP Position: Q3 2020 in Review

Walleye Trading sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2020, closing a stake of 26,619 shares — an estimated $101K sold.

Walleye Trading first reported a position in SBBP in Q2 2020 and held it in 1 quarter. The position peaked at $101K in Q2 2020. 77 funds tracked by Wall St. Rank hold SBBP as of Q3 2020.

Walleye Trading reported no remaining Strongbridge Biopharma plc. position as of Q3 2020 after selling out during the quarter.
Walleye Trading sold 26,619 Strongbridge Biopharma plc. shares in Q3 2020, an estimated $101K.
Walleye Trading first reported a position in Strongbridge Biopharma plc. in Q2 2020 and held it in 1 quarter.
Walleye Trading's Strongbridge Biopharma plc. position peaked at $101K in Q2 2020.
77 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.